FRAGMIN Resource Center
Eisai offers resources to assist you and your staff in the education and administration of FRAGMIN.Learn more >
FRAGMIN Self-Injection Demo Video
This Self-Injection Demo Video walks patients through the steps of injecting with a fixed-dose or graduated syringe.Learn more >
FRAGMIN Patient Education and Administration Kits
Educational materials, including an easy-to-understand reference chart, a step-by-step product brochure, and a how-to demonstration video, introduce patients to the use of FRAGMIN at home.Learn more >
The CLOT* Study: bleeding comparable to warfarin over 6 months1,2
Randomized Comparison of Low–Molecular-Weight Heparin vs Oral Anticoagulant Therapy for the Prevention of Recurrent Venous Thromboembolism in Patients With Cancer.
†Any bleeding included major bleeding.
Criteria for classifying a bleeding event as major2
- Led to a drop in hemoglobin of at least 2 g/dL
- Occurred at a critical site such as intracranial, spinal/epidural, intraocular, retroperitoneal, or pericardial
- Required transfusion of at least 2 units of blood
- Bleeding associated with death